Red Bone Marrow Dosimetry and Haematotoxicity in 177Lu-DOTATATE PRRT

被引：0
|
作者：
Tshori, S. [1 ]
Glasberg, S. [2 ]
Luder, D. [2 ]
Krausz, Y. [2 ]
Gross, D. [2 ]
Schwartz, A. [2 ]
Freedman, N. [2 ,3 ]
机构：
[1] Kaplan Med Ctr, Rehovot, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[3] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0808
引用
收藏
页码：S775 / S776
页数：2
相关论文
共 50 条
  • [1] An image based method for bone marrow dosimetry in 177Lu-DOTATATE therapy
    Svensson, J.
    Soderstrom, J.
    Magnander, T.
    Wikberg, E.
    Wangberg, B.
    Bernhardt, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S9 - S9
  • [2] Bone-Marrow dosimetry with 177Lu-DOTATATE treatment in a hemodialysis patient.
    Chaib, S.
    Tylski, P.
    Lachachi, C.
    Keniza, T.
    Levigoureux, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S218 - S219
  • [3] A Phase II Trial of Dose Escalation in 177Lu-DOTATATE PRRT - the Need for Dosimetry
    Sundlov, A.
    Svensson, J.
    Gleisner, K. Sjogreen
    Ljungberg, M.
    Bernhardt, P.
    Hindorf, C.
    Mortensen, N.
    Morin, K.
    Hermann, R.
    Wangberg, B.
    Ohlsson, T.
    Forssell-Aronsson, E.
    Tennvall, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S225 - S225
  • [4] Towards a quality assurance for dosimetry in peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE
    Marin, G.
    Vanderlinden, B.
    Wimana, Z.
    Guiot, T.
    Karfis, I.
    Flamen, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S159 - S160
  • [5] 177Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors
    Mileva, Magdalena
    Van Bogaert, Camille
    Marin, Gwennaelle
    Danieli, Rachele
    Artigas, Carlos
    Levillain, Hugo
    Ameye, Lieveke
    Taraji-Schiltz, Loubna
    Stathopoulos, Konstantinos
    Wimana, Zena
    Hendlisz, Alain
    Flamen, Patrick
    Karfis, Ioannis
    [J]. CLINICAL NUCLEAR MEDICINE, 2024, 49 (09) : 847 - 853
  • [6] Optimizing and assessing staff exposure during 177Lu-DOTATATE PRRT
    Ben Reguiga, M.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [7] Characterisation of a planar dosimetry method estimating the absorbed dose to the bone marrow during 177Lu-DOTATATE treatment
    Hagmarker, L.
    Svensson, J.
    Magnander, T.
    Hemmingsson, J.
    Gjertsson, P.
    Bernhardt, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S120 - S120
  • [8] Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of 177Lu-DOTATATE PRRT
    Medaer, Eva
    Verslype, Chris
    Van Cutsem, Eric
    Dekervel, Jeroen
    Clement, Paul M.
    Nackaerts, Kristiaan
    Laenen, Annouschka
    Gheysens, Olivier
    Goffin, Karolien
    Jentjens, Sander
    Van Laere, Koen
    Deroose, Christophe M.
    [J]. ACTA ONCOLOGICA, 2020, 59 (06) : 644 - 651
  • [9] 177Lu-DOTATATE PRRT for Multiple Unusual Metastatic Sites in Neuroendocrine Tumor
    Parghane, Rahul, V
    Basu, Sandip
    [J]. CLINICAL NUCLEAR MEDICINE, 2022, 47 (10) : 874 - 875
  • [10] Influence of Pretreatment with Everolimus and/or Sunitinib on the Acute Hematotoxicity of 177Lu-DOTATATE PRRT
    Medaer, E.
    Verslype, C.
    Van Cutsem, E.
    Dekervel, J.
    Clement, P.
    Nackaerts, K.
    Gheysens, O.
    Goffin, K.
    Jentjens, S.
    Van Laere, K.
    Deroose, C. M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S89 - S90
12345